Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H13NO3 |
| Molecular Weight | 195.2151 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC2=C(OCO2)C=C1)NO
InChI
InChIKey=FNDCTJYFKOQGTL-UHFFFAOYSA-N
InChI=1S/C10H13NO3/c1-7(11-12)4-8-2-3-9-10(5-8)14-6-13-9/h2-3,5,7,11-12H,4,6H2,1H3
| Molecular Formula | C10H13NO3 |
| Molecular Weight | 195.2151 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines. | 2007 Dec |
|
| Degradation of N-hydroxy-3,4-methylenedioxymethamphetamine in aqueous solution and its prevention. | 2009 Dec 15 |
|
| Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry. | 2010 May 20 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:28:21 GMT 2023
by
admin
on
Sat Dec 16 11:28:21 GMT 2023
|
| Record UNII |
SJE1T2B1A7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
PiHKAL
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Methylenedioxyhydroxyamphetamine
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
||
|
DEA NO. |
7402
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
74698-47-8
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY | |||
|
PN 005
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY | |||
|
DTXSID30860972
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY | |||
|
SJE1T2B1A7
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY | |||
|
Methylenedioxyhydroxyamphetamine
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY | 3,4-Methylenedioxy-N-hydroxyamphetamine (MDOH, MDH) is an entactogen, psychedelic, and stimulant of the phenethylamine and amphetamine chemical classes. It is the N-hydroxy homologue of MDA, and the N-desmethyl homologue of MDHMA. MDOH was first synthesized and assayed by Alexander Shulgin. | ||
|
98528
Created by
admin on Sat Dec 16 11:28:21 GMT 2023 , Edited by admin on Sat Dec 16 11:28:21 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
